Taken together, we comprehensively conduct a pan-cancer analysis about TOP2A based on the clinical data of The Cancer Genome Atlas (TCGA) database for the first time, including gene expression, clinical survival prognosis, pathological stage, genetic alteration, immune cell infiltration, and immune checkpoints. This evidence concerns the gene TOP2A and cancer.